PRESBYTERIAN MEDICAL CENTER
1. Target Overview & Investment Thesis
PRESBYTERIAN MEDICAL CENTER is a 328-bed suburban community hospital in PHILADELPHIA, PA with $988.5M in net patient revenue and a -18.9% operating margin. The hospital serves a payer mix of 22.8% Medicare, 2.6% Medicaid, and 74.6% commercial.
Thesis: Undervalued. Our ML models identify $72.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -18.9% to -11.5% (+736bps).
| Net Revenue HCRIS | $988.5M |
| Current EBITDA COMPUTED | $-186.4M |
| Operating Margin COMPUTED | -18.9% |
| Occupancy HCRIS | 89.6% |
| Revenue / Bed COMPUTED | $3.0M |
| Net-to-Gross HCRIS | 16.8% |
| Distress Probability ML | 35.4% |
2. Market Context & Competitive Position
PA has 225 Medicare-certified hospitals with a median operating margin of -4.4%. The target's margin of -18.9% places it below the state median. Among 64 size-comparable peers (164-656 beds), the median margin is -6.4%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (164-656), prioritizing same-state peers. 64 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| PRESBYTERIAN MEDICAL CENTER (Target) | PA | 328 | $988.5M | -18.9% |
| ST. LUKES HOSPITAL | PA | 633 | $8.94B | 87.9% |
| MILTON S. HERSHEY MEDICAL CENT | PA | 616 | $2.08B | -2.8% |
| GEISINGER MEDICAL CENTER | PA | 525 | $1.58B | 4.1% |
| YORK HOSPITAL | PA | 533 | $1.47B | 9.7% |
| LANCASTER GENERAL HOSPITAL | PA | 620 | $1.33B | -2.6% |
| UPMC PINNACLE HOSPITALS | PA | 561 | $1.29B | 8.9% |
| READING HOSPITAL AND MEDICAL C | PA | 561 | $1.15B | 6.1% |
| ALLEGHENY GENERAL HOSPITAL | PA | 528 | $919.7M | -0.1% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $72.8M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $20.8M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $19.8M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $19.6M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $12.0M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $633K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-186.4M |
| + RCM Uplift | +$72.8M |
| Pro Forma EBITDA | $-113.6M |
| Current Margin | -18.9% |
| Pro Forma Margin | -11.5% |
| WC Released (1x) | $37.9M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-286.8M | $-502.0M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-286.8M | $-645.3M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-258.1M | $-498.4M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-258.1M | $-619.9M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-315.5M | $-772.7M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-315.5M | $-952.4M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 64 hospitals with 164-656 beds
- Same-state prioritization (n=65)
- Comp margins: P25=-16.1% / P50=-6.4% / P75=0.8%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.